31 – 40 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Rationale and design of the BeyeOMARKER study : prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic
(
- Contribution to journal › Article
-
Mark
The impact of tau-PET in a selected memory clinic cohort : rationale and design of the TAP-TAU study
(
- Contribution to journal › Article
-
Mark
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer’s Disease
(
- Contribution to journal › Scientific review
-
Mark
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217
(
- Contribution to journal › Article
-
Mark
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction : The AD-RIDDLE Project
(
- Contribution to journal › Article
- 2023
-
Mark
Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
APOE -ε4 modulates the association between regional amyloid deposition and cognitive performance in cognitively unimpaired middle-aged individuals
(
- Contribution to journal › Article
-
Mark
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum
(
- Contribution to journal › Article
-
Mark
Functional gradients of the medial parietal cortex in a healthy cohort with family history of sporadic Alzheimer’s disease
(
- Contribution to journal › Article